Association of Impaired Reactive Aldehyde Metabolism with Delayed Graft Function in Human Kidney Transplantation
Table 2
Patient characteristics for validation studies.
Living donor kidney transplant ()
Deceased donor kidney transplant ()
Age of recipient (yrs)
58 ± 4
56 ± 4
Sex of recipient (% males)
70%
60%
Age of donor (yrs)
58 ± 2
57 ± 4
Sex of donor (% males)
50%
70%
Cold ischemia time (min)
221 ± 18
900 ± 88
Hospital stay (days)
8 ± 2
15 ± 3
Recipient cause of renal failure
Glomerulonephritis
40%
30%
Polycystic kidney disease
20%
20%
Diabetes mellitus type 2
0%
20%
Obstructive uropathy
10%
10%
Malignant hypertension
10%
10%
Renal failure
20%
10%
Donor cause of death
Living donor
100%
CVA
20%
SAB
20%
Trauma
20%
CA-OHCA-AMI
30%
Suicide
10%
Miscellaneous
0%
Histocompatibility (HLA mismatches, %)
0
0%
10%
1
10%
10%
2
0%
30%
3
10%
40%
4
20%
0%
5
40%
10%
6
20%
0%
A total of 20 patients were recruited. When comparing recipients of a living donor transplant to recipients of a deceased donor transplant, significant differences were noted for developing delayed graft function, duration of ischemia, and length of posttransplantation hospital stay. , CVA = cerebrovascular accident, SAB = subarachnoid bleeding, CA = cardiac arrest, OHCA = out of hospital cardiac arrest, AMI = acute myocardial infarction.
